Loading chart…
PRE-MARKET
Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. The company offers anti-diabetic, anti-infective, anti-inflammatory, antifungal, antihemorrhoidal, antimalarial, antiseptic, cardiovascular, dermatological, gastrointestinal, gynaecology, neoro/cns, ophthalmic, otc drugs, respiratory, urology, and supplementary drug products, as well as engages in pain management services. It exports its products.
Bliss GVS Pharma Limited (BLISSGVS) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The BLISSGVS share price is ₹614.25 (-2.88% today), with a market capitalisation of ₹65B and a price-to-earnings (P/E) ratio of 41.3. MarketRipple tracks the BLISSGVS investment thesis, the ripple-chain impact of market events on Bliss GVS Pharma Limited, and the Healthcare sector outlook.
Open
₹626.10
High
₹635.80
Low
₹613.00
Prev. Close
₹632.45
52W High
₹739.90
52W Low
₹118.00
Day range
₹613.00–₹635.80
52-week range
₹118.00–₹739.90
Volume
76K
P/E
41.3
ROE
10.8%
D/E
0.02
Margin
13.5%
Bliss GVS Pharma Limited (NSE: BLISSGVS) is currently trading at ₹614.25 (-2.88%).
Bliss GVS Pharma Limited's market capitalization is ₹65B.
Bliss GVS Pharma Limited's price-to-earnings (P/E) ratio is 41.3.
Bliss GVS Pharma Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).